Paolo Chiodini
Overview
Explore the profile of Paolo Chiodini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
263
Citations
5847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paoletti E, Ruotolo C, Marzano F, Borrelli S, Garofalo C, Chiodini P, et al.
J Hypertens
. 2025 Mar;
PMID: 40079822
Objectives: Identification of nondialysis chronic kidney disease (CKD) patients at a higher risk of end-stage kidney disease (ESKD) or adverse cardiovascular events is the first essential step to optimize management....
2.
Alfieri A, Di Franco S, Passavanti M, Pace M, Simeon V, Chiodini P, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005772
Antimicrobial lock therapy (ALT) prevents microbial colonization in central vein catheters and treats existing catheter-related bloodstream infections (CRBSIs); the ALT assessment involves several key considerations. First, identifying which patients are...
3.
Leonardi B, Natale G, Leone F, Messina G, Fiorito R, Coppolino F, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
2(2):166-171.
PMID: 39790137
Background: Paravertebral block (PVB) is effective in controlling postoperative pain after video-assisted thoracoscopic surgery (VATS) lobectomy but is subject to a high rate of failure because of incorrect site of...
4.
Ren X, Nicolas G, Frenoy P, Papier K, Moreno-Iribas C, Masala G, et al.
Diabetes Metab
. 2024 Nov;
50(6):101587.
PMID: 39521120
Aims/hypothesis: The aim of the present study was to investigate the association between dietary exposures to dioxins, dioxin-like polychlorinated biphenyls (DL-PCBs) and non-dioxin-like polychlorinated biphenyls (NDL-PCBs) and the incidence of...
5.
Indraccolo S, Signoriello S, Piga I, Esposito G, Ferrarini F, Boscolo Bragadin A, et al.
Int J Biol Markers
. 2024 Nov;
39(4):328-337.
PMID: 39513196
Introduction: In ovarian cancer, expression of metabolism-related markers has been investigated in several studies focusing on individual markers; however, a parallel quantitative evaluation of markers mapping to distinct metabolic processes...
6.
Borrelli S, Garofalo C, Reboldi G, Coppola A, Chiodini P, Simeoni M, et al.
Clin Kidney J
. 2024 Nov;
17(11):sfae316.
PMID: 39502370
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower ambulatory blood pressure (ABP) in patients with type 2 diabetes mellitus; whether the same holds true in diabetic kidney disease (DKD) is unknown....
7.
Rocco N, Catanuto G, Accardo G, Velotti N, Chiodini P, Cinquini M, et al.
Cochrane Database Syst Rev
. 2024 Oct;
10:CD013821.
PMID: 39479986
Background: Women who have a mastectomy for breast cancer treatment or risk reduction may be offered different options for breast reconstruction, including use of implants or the woman's own tissue...
8.
Bignotti E, Simeon V, Ardighieri L, Kuhn E, Marchini S, Califano D, et al.
Int J Cancer
. 2024 Oct;
156(5):1085-1096.
PMID: 39415516
To date, there are no biomarkers that define a patient subpopulation responsive to bevacizumab (BEV), an effective treatment option for advanced ovarian carcinoma (OC). In the context of the MITO16A/MaNGO...
9.
Fiore M, Alfieri A, Torretta G, Passavanti M, Sansone P, Pota V, et al.
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338290
Alcohol withdrawal syndrome (AWS) is defined as the cessation or reduction in heavy and prolonged alcohol use within several hours to a few days of cessation. The recommended first-line therapy...
10.
Mallardo D, Fordellone M, White A, Vowinckel J, Bailey M, Sparano F, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273294
Resistance biomarkers are needed to identify patients with advanced melanoma obtaining a response to ICI treatment and developing resistance later. We searched a combination of molecular signatures of response to...